Protagenic Therapeutics (PTIX) Stock Chart & Stock Price History $0.62 -0.07 (-10.17%) (As of 11/15/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsInsider TradesSEC FilingsShort InterestTrends Protagenic Therapeutics Stock Price Performance 5 Day Performance-19.73%1 Month Performance+10.57%3 Month Performance+16.40%6 Month Performance-58.52%Year-To-Date Performance-37.57%1 Year Performance-23.70% Receive PTIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protagenic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Let’s be blunt (Ad)Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now PTIX Stock Chart for Saturday, November, 16, 2024 PTIX Chart by TradingView Protagenic Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/15/2024$0.69$0.62-10.52%$0.71$0.6218,527 shs$2.76 million11/14/2024$0.65$0.69+6.26%$0.73$0.6038,844 shs$3.09 million11/13/2024$0.80$0.65-18.75%$0.85$0.52366,793 shs$2.91 million11/12/2024$0.77$0.80+3.90%$1.09$0.633.16 million shs$3.58 million11/11/2024$0.60$0.77+28.31%$0.78$0.60127,239 shs$3.44 million11/08/2024$0.63$0.60-4.75%$0.63$0.5913,079 shs$2.68 million Get the Latest News and Ratings for PTIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protagenic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/07/2024$0.62$0.63+2.44%$0.63$0.592,924 shs$2.82 million11/06/2024$0.63$0.62-2.38%$0.78$0.6130,014 shs$2.71 million11/05/2024$0.61$0.63+3.79%$0.70$0.6019,816 shs$2.82 million11/04/2024$0.61$0.61-0.20%$0.64$0.6126,715 shs$2.71 million11/01/2024$0.66$0.61-7.16%$0.65$0.6122,619 shs$2.72 million10/31/2024$0.66$0.66-0.02%$0.66$0.5848,646 shs$2.93 million10/30/2024$0.64$0.66+2.86%$0.66$0.5763,639 shs$2.93 million10/29/2024$0.64$0.64-0.31%$0.80$0.55488,027 shs$2.85 million10/28/2024$0.61$0.64+4.24%$0.67$0.5467,014 shs$2.85 million10/25/2024$0.64$0.61-4.26%$0.67$0.6115,349 shs$2.73 million10/24/2024$0.69$0.64-6.72%$0.70$0.6422,416 shs$2.85 million10/23/2024$0.64$0.69+6.92%$0.71$0.6434,640 shs$3.06 million10/22/2024$0.70$0.64-8.29%$0.70$0.6239,546 shs$2.86 million10/21/2024$0.55$0.70+27.71%$0.82$0.58310,340 shs$3.12 million10/18/2024$0.54$0.55+1.50%$0.55$0.523,591 shs$2.44 million10/17/2024$0.56$0.54-3.40%$0.59$0.538,061 shs$2.40 million10/16/2024$0.55$0.56+1.43%$0.58$0.5364,753 shs$2.49 million10/15/2024$0.53$0.55+3.96%$0.59$0.5356,689 shs$2.45 million Related Companies CERo Therapeutics Stock Price Chart Turnstone Biologics Stock Price Chart RedHill Biopharma Stock Price Chart PHAXIAM Therapeutics Stock Price Chart Senti Biosciences Stock Price Chart Kiora Pharmaceuticals Stock Price Chart Eagle Pharmaceuticals Stock Price Chart Vincerx Pharma Stock Price Chart Biora Therapeutics Stock Price Chart Conduit Pharmaceuticals Stock Price Chart Receive PTIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protagenic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PTIX) was last updated on 11/16/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored🗓️ My First LIVE Event in 5 Years!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Behind the Markets | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protagenic Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protagenic Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
